Clinical Trial Update: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel and carboplatin versus ifosfamide in newly diagnosed, persistent, or recurrent uterine, ovarian, fallopian tube, or primary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Uterine Cancer

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• Paclitaxel and Carboplatin

Snippet

Sponsor: GOG Foundation | Conditions: Mixed Mesodermal (Mullerian) Tumor, Ovarian Carcinosarcoma | Phase 3 | Status: UNKNOWN | Results posted: 2020-08-10